-
1
-
-
33645802169
-
Cyclin-dependent kinase pathways as targets for cancer treatment
-
Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24: 1770-1783, 2006.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1770-1783
-
-
Shapiro, G.I.1
-
2
-
-
0033564697
-
CDK inhibitors: Positive and negative regulators of G1-phase progression
-
Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
-
(1999)
Genes Dev
, vol.13
, pp. 1501-1512
-
-
Sherr, C.J.1
Roberts, J.M.2
-
3
-
-
44549087848
-
Cyclin-dependent kinase 9: A key transcriptional regulator and potential drug target in oncology, virology and cardiology
-
Wang S and Fischer PM: Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends in Pharmacol Sci Rev 29: 302-313, 2008.
-
(2008)
Trends in Pharmacol Sci Rev
, vol.29
, pp. 302-313
-
-
Wang, S.1
Fischer, P.M.2
-
4
-
-
1842832323
-
CDK9: From basal transcription to cancer and AIDS
-
Falco GD and Giordano A: CDK9: From basal transcription to cancer and AIDS. Cancer Biol Ther Rev 1: 342-347, 2002.
-
(2002)
Cancer Biol Ther Rev
, vol.1
, pp. 342-347
-
-
Falco, G.D.1
Giordano, A.2
-
5
-
-
0036136668
-
Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control
-
Oelgeschlager T: Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J Cell Phys 190: 160-169, 2002.
-
(2002)
J Cell Phys
, vol.190
, pp. 160-169
-
-
Oelgeschlager, T.1
-
6
-
-
0028880855
-
Cyclins, cyclindependent kinases and CDK inhibitors: Implications in cell cycle control and cancer
-
MacLachlan TK, Sang N and Giordano A: Cyclins, cyclindependent kinases and CDK inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5: 127-156, 1995.
-
(1995)
Crit Rev Eukaryot Gene Expr
, vol.5
, pp. 127-156
-
-
Maclachlan, T.K.1
Sang, N.2
Giordano, A.3
-
7
-
-
0034543419
-
Cell-cycle dysregulation in breast cancer therapies targeting the cell cycle
-
Zafonte BT, Hulit J, Amanatullah DF, Albanese C, Wang C, Rosen E, Reutens A, Sparano, JA, Lisanti MP and Pestell RG: Cell-cycle dysregulation in breast cancer therapies targeting the cell cycle. Frontiers Biosci 5: D938-D961, 2000.
-
(2000)
Frontiers Biosci
, vol.5
, pp. D938-D961
-
-
Zafonte, B.T.1
Hulit, J.2
Amanatullah, D.F.3
Albanese, C.4
Wang, C.5
Rosen, E.6
Reutens, A.7
Sparano, J.A.8
Lisanti, M.P.9
Pestell, R.G.10
-
8
-
-
0031670668
-
Phase i trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor in patients with refractory neoplasms
-
Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG, Sausville EA: Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor in patients with refractory neoplasms. J Clin Oncol 16: 2986-2999, 1998.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2986-2999
-
-
Senderowicz, A.M.1
Headlee, D.2
Stinson, S.F.3
Lush, R.M.4
Kalil, N.5
Villalba, L.6
Hill, K.7
Steinberg, S.M.8
Figg, W.D.9
Tompkins, A.10
Arbuck, S.G.11
Sausville, E.A.12
-
9
-
-
0034665961
-
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
-
Chao S, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM and Price DH: Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 275: 28345-28348, 2000.
-
(2000)
J Biol Chem
, vol.275
, pp. 28345-28348
-
-
Chao, S.1
Fujinaga, K.2
Marion, J.E.3
Taube, R.4
Sausville, E.A.5
Senderowicz, A.M.6
Peterlin, B.M.7
Price, D.H.8
-
10
-
-
84856021037
-
Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis
-
Wang K, Hampson P, Hazeldine J, Krystof V, Strnad M, Pechan P and Janet M: Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis. PLoS ONE 7: e30128, 2012.
-
(2012)
PLoS ONE
, vol.7
, pp. e30128
-
-
Wang, K.1
Hampson, P.2
Hazeldine, J.3
Krystof, V.4
Strnad, M.5
Pechan, P.6
Janet, M.7
-
11
-
-
20444477948
-
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1
-
MacCallum DE, Melville J, Frame S, Watt K, Anderson S, Gianella-Borradori A, Lane DP and Green SR: Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res 65: 5399-407, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 5399-5407
-
-
Maccallum, D.E.1
Melville, J.2
Frame, S.3
Watt, K.4
Anderson, S.5
Gianella-Borradori, A.6
Lane, D.P.7
Green, S.R.8
-
12
-
-
66549124708
-
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
-
Chen R1, Wierda WG, Chubb S, Hawtin RE, Fox JA, Keating MJ, Gandhi V and Plunkett W: Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia. Blood 113: 4637-4645, 2009.
-
(2009)
Blood
, vol.113
, pp. 4637-4645
-
-
Chen, R.1
Wierda, W.G.2
Chubb, S.3
Hawtin, R.E.4
Fox, J.A.5
Keating, M.J.6
Gandhi, V.7
Plunkett, W.8
-
13
-
-
77951579858
-
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
-
Santo L, Vallet S, Hideshima T, Cirstea D, Ikeda H, Pozzi S, Patel K, Okawa Y, Gorgun G, Perrone G, Calabrese E, Yule M, Squires M, Ladetto M, Boccadoro M, Richardson PG, Munshi NC, Anderson KC and Raje N: AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition. Oncogene 29: 2325-2336, 2010.
-
(2010)
Oncogene
, vol.29
, pp. 2325-2336
-
-
Santo, L.1
Vallet, S.2
Hideshima, T.3
Cirstea, D.4
Ikeda, H.5
Pozzi, S.6
Patel, K.7
Okawa, Y.8
Gorgun, G.9
Perrone, G.10
Calabrese, E.11
Yule, M.12
Squires, M.13
Ladetto, M.14
Boccadoro, M.15
Richardson, P.G.16
Munshi, N.C.17
Anderson, K.C.18
Raje, N.19
-
14
-
-
0038745560
-
Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells
-
Raju U, Nakata E, Mason KA, Ang KK and Milas L: Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Cancer Res 63: 3263-3267, 2003.
-
(2003)
Cancer Res
, vol.63
, pp. 3263-3267
-
-
Raju, U.1
Nakata, E.2
Mason, K.A.3
Ang, K.K.4
Milas, L.5
-
15
-
-
84896040809
-
A phase i trial of flavopiridol in relapsed multiple myeloma
-
Hofmeister CC, Poi M, Bowers MA, Zhao W, Phelps MA, Benson DM, Kraut EH, Farag S, Efebera YA, Sexton J, Lin TS, Grever M and Byrd JC: A phase I trial of flavopiridol in relapsed multiple myeloma. Cancer Chemother Pharmacol 73: 249-257, 2014.
-
(2014)
Cancer Chemother Pharmacol
, vol.73
, pp. 249-257
-
-
Hofmeister, C.C.1
Poi, M.2
Bowers, M.A.3
Zhao, W.4
Phelps, M.A.5
Benson, D.M.6
Kraut, E.H.7
Farag, S.8
Efebera, Y.A.9
Sexton, J.10
Lin, T.S.11
Grever, M.12
Byrd, J.C.13
-
16
-
-
0018189199
-
Inhibition of mammalian RNA polymerase by 5, 6-dichloro-ribofuranosylbenzimidazole (DRB) and DRB triphosphate
-
Dreyer C and Hausen P: Inhibition of mammalian RNA polymerase by 5, 6-dichloro-ribofuranosylbenzimidazole (DRB) and DRB triphosphate. Nucleic Acids Res 5: 3325-3335, 1978.
-
(1978)
Nucleic Acids Res
, vol.5
, pp. 3325-3335
-
-
Dreyer, C.1
Hausen, P.2
-
17
-
-
77956968392
-
Halogen bonds form the basis for selective P-TEFb inhibition by DRB
-
Baumli S, Endicott JA and Johnson LN: Halogen bonds form the basis for selective P-TEFb inhibition by DRB. Chem Biol 17: 931-936, 2010.
-
(2010)
Chem Biol
, vol.17
, pp. 931-936
-
-
Baumli, S.1
Endicott, J.A.2
Johnson, L.N.3
-
18
-
-
34548232360
-
P-TEFb is a crucial co-factor for Myc transactivation
-
Gargano B, Amente S, Majello B and Lania L: P-TEFb is a crucial co-factor for Myc transactivation. Cell Cycle 6: 2031-2037, 2007.
-
(2007)
Cell Cycle
, vol.6
, pp. 2031-2037
-
-
Gargano, B.1
Amente, S.2
Majello, B.3
Lania, L.4
-
19
-
-
0034769605
-
MAPK dependence of DNA damage repair: Ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion
-
Yacoub A, Park JS, Qiao L, Dent P, Hagan MP: MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. Int J Radiat Biol 77: 1067-1078, 2001.
-
(2001)
Int J Radiat Biol
, vol.77
, pp. 1067-1078
-
-
Yacoub, A.1
Park, J.S.2
Qiao, L.3
Dent, P.4
Hagan, M.P.5
-
20
-
-
1642481261
-
Phosphorylation and nuclear accumulation are distinct events contributing to the activation of p53
-
OHagan HM, Ljungman M: Phosphorylation and nuclear accumulation are distinct events contributing to the activation of p53. Mutat Res 546: 7-15, 2004.
-
(2004)
Mutat Res
, vol.546
, pp. 7-15
-
-
Ohagan, H.M.1
Ljungman, M.2
-
21
-
-
84886313181
-
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma
-
Li C, Brand TM, Iida M, Huang S, Armstrong EA, van der Kogel A and Wheeler DL: Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma. Discov Med 16: 79-92, 2013.
-
(2013)
Discov Med
, vol.16
, pp. 79-92
-
-
Li, C.1
Brand, T.M.2
Iida, M.3
Huang, S.4
Armstrong, E.A.5
Van Der Kogel, A.6
Wheeler, D.L.7
-
22
-
-
84871300677
-
Dasatinib, a multikinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways
-
Raju U, Riesterer O, Wang ZQ, Molkentine DP, Molkentine JM, Johnson FM, Glisson B, Milas L and Ang KK: Dasatinib, a multikinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiother Oncol 105: 241-249, 2012.
-
(2012)
Radiother Oncol
, vol.105
, pp. 241-249
-
-
Raju, U.1
Riesterer, O.2
Wang, Z.Q.3
Molkentine, D.P.4
Molkentine, J.M.5
Johnson, F.M.6
Glisson, B.7
Milas, L.8
Ang, K.K.9
-
23
-
-
84865699798
-
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation
-
Matsumoto F, Valdecanas DN, Mason KA, Milas L, Ang KK and Raju U: The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation. Anticancer Res 32: 3029-3035, 2012.
-
(2012)
Anticancer Res
, vol.32
, pp. 3029-3035
-
-
Matsumoto, F.1
Valdecanas, D.N.2
Mason, K.A.3
Milas, L.4
Ang, K.K.5
Raju, U.6
-
24
-
-
0034632675
-
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways
-
Blaydes JP, Craig AL, Wallace M, Ball HML, Traynor NJ, Gibbs NK and Hupp TR: Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene 19: 3829-3839, 2000.
-
(2000)
Oncogene
, vol.19
, pp. 3829-3839
-
-
Blaydes, J.P.1
Craig, A.L.2
Wallace, M.3
Hml, B.4
Traynor, N.J.5
Gibbs, N.K.6
Hupp, T.R.7
-
25
-
-
84897969159
-
Revisiting p53 for cancer-specific chemo-and radiotherapy
-
Beckta JM, Ahmad SF, Yang H, and Valerie K: Revisiting p53 for cancer-specific chemo-and radiotherapy. Cell Cycle 13: 710-713, 2014.
-
(2014)
Cell Cycle
, vol.13
, pp. 710-713
-
-
Beckta, J.M.1
Ahmad, S.F.2
Yang, H.3
Valerie, K.4
-
26
-
-
0013973616
-
X-Ray sensitivity during the cell generation cycle of cultured Chinese hamster cells
-
Sinclair WK and Mortan RA: X-Ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29: 450-474, 1966.
-
(1966)
Radiat Res
, vol.29
, pp. 450-474
-
-
Sinclair, W.K.1
Mortan, R.A.2
-
27
-
-
84857852626
-
Inhibition of casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition
-
Dixit D, Sharma V, Ghosh S, Mehta VS and Sen E: Inhibition of casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition. Cell Death Dis 3: e271, 2012.
-
(2012)
Cell Death Dis
, vol.3
, pp. e271
-
-
Dixit, D.1
Sharma, V.2
Ghosh, S.3
Mehta, V.S.4
Sen, E.5
-
28
-
-
84896871202
-
SIRT1 is up-regulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis
-
Nihal M, Ahmad N, and Wood GS: SIRT1 is up-regulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle 13: 632-640, 2014.
-
(2014)
Cell Cycle
, vol.13
, pp. 632-640
-
-
Nihal, M.1
Ahmad, N.2
Wood, G.S.3
-
29
-
-
84863318544
-
SirT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions
-
Xie Y, Zhang J, Ye S, He M, Ren R, Yuan D and Shao C: SirT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions. Cancer Sci 103: 1238-1244, 2012.
-
(2012)
Cancer Sci
, vol.103
, pp. 1238-1244
-
-
Xie, Y.1
Zhang, J.2
Ye, S.3
He, M.4
Ren, R.5
Yuan, D.6
Shao, C.7
-
30
-
-
84863568651
-
Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells
-
Kroonen J, Artesi M, Capraro V, Nguyen-Khac M, Willems M, Chakravarti A, Bours V and Robe PA: Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. Int J Oncol 41: 776-782, 2012.
-
(2012)
Int J Oncol
, vol.41
, pp. 776-782
-
-
Kroonen, J.1
Artesi, M.2
Capraro, V.3
Nguyen-Khac, M.4
Willems, M.5
Chakravarti, A.6
Bours, V.7
Robe, P.A.8
-
31
-
-
79960051228
-
CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation
-
Lin Y, Hung M, Lin C, Li J, Lee K, Li Y, Chen M, Chen J and Yang C: CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation. Cancer Biother Radiopharm 26: 381-388, 2011.
-
(2011)
Cancer Biother Radiopharm
, vol.26
, pp. 381-388
-
-
Lin, Y.1
Hung, M.2
Lin, C.3
Li, J.4
Lee, K.5
Li, Y.6
Chen, M.7
Chen, J.8
Yang, C.9
|